Clinical Trial: Effectiveness of Two Approved Drugs in Lowering High Cholesterol

This study is no longer recruiting patients.

Sponsored by: Merck
Information provided by: Merck

Purpose

The purpose of this study is to evaluate the safety and effectiveness of two approved drugs in lowering high cholesterol when taken together, compared to taking only one of the drugs.

Condition Treatment or Intervention Phase
Hypercholesterolemia
 
Phase II
Phase III

MedlinePlus related topics:  Cholesterol

Study Type: Interventional
Study Design: Treatment, Randomized, Double-Blind, Active Control, Parallel Assignment, Efficacy Study

Official Title: To Compare the Effectiveness of Two Approved Drugs in Lowering High Cholesterol

Eligibility

Ages Eligible for Study:  21 Years   -   65 Years,  Genders Eligible for Study:  Both

Criteria

Inclusion Criteria:

  • Elevated cholesterol level

Exclusion Criteria:

  • Liver disease
  • Known allergies to study drugs

More Information

Study ID Numbers:  2004_060
Record last reviewed:  September 2004
Last Updated:  October 13, 2004
Record first received:  September 21, 2004
ClinicalTrials.gov Identifier:  NCT00092157
Health Authority: United States: Food and Drug Administration
ClinicalTrials.gov processed this record on 2005-04-08


Source: ClinicalTrials.gov
Cache Date: April 9, 2005

Resources